Company / Operating Income
AbCellera Biologics Inc. Operating Income History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$217.1M
FY2025
5-year range
-$314.8M / $156.0M
FY2021-FY2025
Trend
+31.0%
vs FY2024
Sector context
#151 of 204
Health Care
What the data says
At -$217M, AbCellera Biologics Inc.'s operating income ranks #151 of 204 in the Health Care sector. Operating Income returned to growth in FY2025 after 2 years of decline, reaching -$217M.
Based on SEC 10-K filings.
-$217M in FY2025.
Improved from -$237M to -$217M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#151 of 204 in Health CareTop 74% of 204This company -$217.1M Sector average $107.8M
▼
-301.5% below sector average
Key checks
Key Insights
- In FY2025, operating income increased 31.0% year-over-year.
- Ranks #151 out of 204 companies in the Health Care sector.
- Peak operating income was recorded in FY2022.
- Lowest operating income in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 0.93 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$217.1M | +31.0% |
| FY2024 | -$314.8M | -32.7% |
| FY2023 | -$237.2M | -252.0% |
| FY2022 | $156.0M | +3889.9% |
| FY2021 | -$4.1M | -102.6% |
| FY2020 | $156.0M | +3889.9% |
| FY2019 | -$4.1M | - |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026